Future prospects for CD8 + regulatory T cells in immune tolerance

Archive ouverte

Flippe, Léa | Bézie, Séverine | Anegon, Ignacio | Guillonneau, Carole

Edité par CCSD ; Wiley -

International audience. CD8+ Tregs have been long described and significant progresses have been made about their phenotype, their functional mechanisms, and their suppressive ability compared to conventional CD4+ Tregs. They are now at the dawn of their clinical use. In this review, we will summarize their phenotypic characteristics, their mechanisms of action, the similarities, differences and synergies between CD8+ and CD4+ Tregs, and we will discuss the biology, development and induction of CD8+ Tregs, their manufacturing for clinical use, considering open questions/uncertainties and future technically accessible improvements notably through genetic modifications.

Suggestions

Du même auteur

IL‐34 deficiency impairs FOXP3 + Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis

Archive ouverte | Freuchet, Antoine | CCSD

International audience. Background: Immune homeostasis requires fully functional Tregs with a stable phenotype to control autoimmunity. Although IL-34 is a cytokine first described as mainly involved in monocyte cel...

Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity

Archive ouverte | Benallegue, Naïl | CCSD

Naïl Benallegue, Bryan Nicol, David A. Laplaud and Carole Guillonneau are co-authors.. International audience. Autoimmune diseases can develop following pathological activation of autoreactive effector cells and/or,...

Single cell transcriptomic analysis for a better understanding of heterogeneity in human CD8 regulatory T cells

Archive ouverte | Sérazin, Céline | CCSD

International audience

Chargement des enrichissements...